α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth

Acta Neuropathologica

Volumn 127, Issue 4, 2014, Pages 593-603

  Sengupta, Soma ^a,f   Weeraratne, Shyamal Dilhan ^a   Sun, Hongyu ^a,e   Phallen, Jillian ^c   Rallapalli, Sundari K ^b   Teider, Natalia ^a   Kosaras, Bela ^a   Amani, Vladimir ^a   Pierre Francois, Jessica ^a   Tang, Yujie ^d   Nguyen, Brian ^d   Yu, Furong ^d   Schubert, Simone ^d   Balansay, Brianna ^d   Mathios, Dimitris ^c   Lechpammer, Mirna ^a,g   Archer, Tenley C ^a   Tran, Phuoc ^c   Reimer, Richard J ^d   Cook, James M ^b   Lim, Michael ^c   Jensen, Frances E ^a,e   Pomeroy, Scott L ^a   Cho, Yoon Jae ^d   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GABRA5; HOXA5; Medulloblastoma; MYC; QHii066

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; ANTINEOPLASTIC AGENT; CISPLATIN; MYC PROTEIN; PROTEIN P53; QHII 066; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EVOKED RESPONSE; EX VIVO STUDY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MEDULLOBLASTOMA; MEMBRANE STEADY POTENTIAL; MOUSE; NEURAL CREST; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; SUBVENTRICULAR ZONE; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; BENZODIAZEPINES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CISPLATIN; COLONY-FORMING UNITS ASSAY; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MEDULLOBLASTOMA; MEMBRANE POTENTIALS; MICE; PATCH-CLAMP TECHNIQUES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, NICOTINIC; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896543307     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1205-7     Document Type: Article

References (41)

1. Alfonso J, Le Magueresse C, Zuccotti A, Khodosevich K, Monyer H (2012) Diazepam binding inhibitor promotes progenitor proliferation in the postnatal SVZ by reducing GABA signaling. Cell Stem Cell 10:76-87. doi:10.1016/j.stem. 2011.11.011
2. Al-Wadei HA, Al-Wadei MH, Ullah MF, Schuller HM (2012) Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice. PLoS ONE 7:e43376. doi:10.1371/journal.pone.0043376
3. Andang M, Hjerling-Leffler J, Moliner A et al (2008) Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature 451:460-464. doi:10.1038/nature06488 (Pubitemid 351158886)
4. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD (1990) Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50(8):2347-2350 (Pubitemid 20134493)
5. Binggeli R, Cameron IL (1980) Cellular potentials of normal and cancerous fibroblasts and hepatocytes. Cancer Res 40:1830-1835 (Pubitemid 10116099)
6. Cancer Genome Atlas Research N (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489:519-525. doi:10.1038/nature11404
7. Chen H, Rubin E, Zhang H et al (2005) Identification of transcriptional targets of HOXA5. J Biol Chem 280:19373-19380. doi:10.1074/jbc.M413528200 (Pubitemid 41379645)
8. Cho YJ, Tsherniak A, Tamayo P et al (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29:1424-1430. doi:10.1200/JCO.2010.28.5148
9. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14(Suppl 5):v1-v49. doi:10.1093/neuonc/nos218
10. Dzhala VI, Talos DM, Sdrulla DA et al (2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11:1205-1213. doi:10.1038/nm1301 (Pubitemid 43093668)
11. Fernando RN, Eleuteri B, Abdelhady S, Nussenzweig A, Andang M, Ernfors P (2011) Cell cycle restriction by histone H2AX limits proliferation of adult neural stem cells. Proc Natl Acad Sci USA 108:5837-5842. doi:10.1073/pnas. 1014993108
12. Fiaschetti G, Castelletti D, Zoller S et al (2011) Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene 30(25):2823-2835. doi: 10.1038/onc.2011.10
13. Hiyama E, Hiyama K, Nishiyama M, Reynolds CP, Shay JW, Yokoyama T (2003) Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J Pediatr Surg 38:1730-1734 (Pubitemid 37505399)
14. Hong Y, Stambrook PJ (2004) Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 101:14443-14448. doi:10.1073/pnas.0401346101 (Pubitemid 39346768)
15. Knoll JH, Cheng SD, Lalande M (1994) Allele specificity of DNA replication timing in the Angelman/Prader-Willi syndrome imprinted chromosomal region. Nat Genet 6:41-46. doi:10.1038/ng0194-41 (Pubitemid 24191911)
16. Li X, Cao H, Zhang C et al (2003) Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1, 4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist. J Med Chem 46:5567-5570. doi:10.1021/jm034164c (Pubitemid 37543306)
17. LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR (1995) GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis
18. Nakagawara A, Ikeda K, Tsuda T, Higashi K (1987) N-myc oncogene amplification and prognostic factors of neuroblastoma in children. J Pediatr Surg 22:895-898 (Pubitemid 17156489)
19. Northcott PA, Korshunov A, Witt H et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408-1414. doi:10.1200/JCO.2009.27.4324
20. Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141-148. doi:10.1016/j. neuropharm.2008.07.045
21. Platt DM, Duggan A, Spealman RD et al (2005) Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther 313:658-667. doi:10.1124/jpet.104.080275 (Pubitemid 40604166)
22. Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106-110. doi:10.1038/nature11329
23. Raman V, Martensen SA, Reisman D et al (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978. doi:10.1038/35016125 (Pubitemid 30435057)
24. Roberts SS, Mori M, Pattee P et al (2004) GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. J Clin Oncol 22:4127-4134. doi:10.1200/JCO.2004.02.032 (Pubitemid 41185182)
25. Robinson G, Parker M, Kranenburg TA et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488(7409):43-48. doi:10.1038/nature11213
26. Ryan SL, Schwalbe EC, Cole M et al (2012) MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol 123:501-513. doi:10.1007/s00401-011- 0923-y
27. Savic MM, Clayton T, Furtmuller R et al (2008) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Res 1208:150-159. doi:10.1016/j.brainres.2008.02.020
28. Serwanski DR, Miralles CP, Christie SB, Mehta AK, Li X, De Blas AL (2006) Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain. J Comp Neurol 499:458-470. doi:10.1002/cne.21115 (Pubitemid 44571940)
29. Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C et al (2013) Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell 152(5):1065-1076. doi:10.1016/j.cell.2013.01.036
30. Strathdee G, Holyoake TL, Sim A et al (2007) Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 13:5048-5055. doi:10.1158/1078-0432.CCR-07-0919 (Pubitemid 47502069)
31. Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550. doi:10.1073/pnas.0506580102 (Pubitemid 41528093)
32. Sur C, Wafford KA, Reynolds DS et al (2001) Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci 21:3409-3418 (Pubitemid 32422806)
33. Tamayo P, Cho YJ, Tsherniak A et al (2011) Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol 29:1415-1423. doi:10.1200/JCO.2010.28.1675
34. Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465-472. doi:10.1007/s00401-011-0922-z
35. Vaknin UA, Hann SR (2006) The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic. J Cell Biochem 97(5):1094-1103
36. van Rijnsoever C, Täuber M, Choulli MK, Keist R, Rudolph U, Mohler H, Fritschy JM, Crestani F (2004) Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24(30):6785-6790 (Pubitemid 38993900)
37. Weeraratne SD, Amani V, Teider N et al (2012) Pleiotropic effects of miR-183-96-182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 123:539-552. doi:10.1007/s00401-012-0969-5
38. Weeraratne SD, Amani V, Neiss A et al (2011) miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol 13:165-175. doi:10.1093/neuonc/noq179
39. Wu KJ, Grandori C, Amacker M et al (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21:220-224. doi:10.1038/6010 (Pubitemid 29070372)
40. Yin W, Majumder S, Clayton T et al (2010) Design, synthesis, and subtype selectivity of 3,6-disubstituted beta-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse. Bioorg Med Chem 18:7548-7564. doi:10.1016/j.bmc.2010.08.049
41. Zhang Y, Adachi M, Zou H, Hareyama M, Imai K, Shinomura Y (2006) Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation. Int J Radiat Oncol Biol Phys 65:859-866. doi:10.1016/j.ijrobp.2006. 03.019 (Pubitemid 43795847)